EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
Introduction Lung cancer is the leading cause of death from cancer worldwide. NSCLC is the most common form accounting for >80% of all cases. Over half of NSCLC patients have developed metastases at the time of diagnosis (stage IV cancer) and 5-year …